IndraLab

Statements


MYSM1 activates RIPK2. 1 / 1
| 1

reach
"Furthermore, overexpression of Mysm1 failed to inhibit phosphorylation at pS176 (Fig. S9A-B) and did not negate the impact of Ripk2 in activating NF-κB and MAPK pathways (Fig. S9C-D)."